Exosome Research Market Size to Reach USD 961.41 Million by 2034

Exosome Research Market Size to Reach USD 961.41 Million by 2034 According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is expected to reach around USD 961.41 million by 2034, growing at a compound annual growth rate (CAGR) of 17.47% over the forecast period […]

Join Class Action to Recover Losses from KBR, Inc. (KBR) – Contact Levi & Korsinsky Before November 18, 2025

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=175162&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Notifies Tronox Holdings plc (TROX) Shareholders of Class Action Lawsuit and November 3, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tronox-holdings-plc-lawsuit-submission-form?prid=175160&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Lawsuit Filed: Cytokinetics, Incorporated (CYTK) – Join by November 17, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=175161&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

December 15, 2025 Deadline Approaching: Join Class Action Against Baxter International, Inc. (BAX) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=175158&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Blazpay enters Phase 3 after raising 1 million dollars and surpassing 139 million tokens sold, marking another major milestone in its presale journey

Blazpay enters Phase 3 after raising 1 million dollars and surpassing 139 million tokens sold, marking another major milestone in its presale journey GlobeNewswire November 03, 2025 PANAMA CITY, Nov. 03, 2025 (GLOBE NEWSWIRE) — Blazpay's AI Crypto Presale 2025 has reached a significant milestone, raising $1 million in Phase 3 with 137 million BLAZ

Investors Urged to Contact Levi & Korsinsky for Information Before November 14, 2025 – Fluor Corporation (FLR)

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=175155&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Faron Hits Key Milestone With Bexmab Phase 2 Completion, Advances To Registrational Trial With Fda Alignment

TURKU, FI / ACCESS Newswire / November 3, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) – Having achieved all primary endpoints and secured FDA alignment, Faron formally concludes enrolment of the BEXMAB Phase 2 trial as Company’s focus shifts to a registrational trial TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM:FARN, First North:FARON), a clinical-stage biopharmaceutical company focused

Securities Lawsuit Alert: WPP plc (WPP) Investors – Contact Levi & Korsinsky Before December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=175152&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Nokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities

Nokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities GlobeNewswire November 03, 2025 Press ReleaseNokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities Nokia's secure mission-critical private networks combined with OneLayer's OT asset visibility and protection help utilities modernize grids with secure 5G/LTE. 3 November 2025Espoo, Finland – Nokia

Scroll to Top